Sham L. Pahuja

Steroidal fatty acid esters

Several years ago we discovered an unexpected family of steroidal metabolites, steroidal fatty acid esters. We found that fatty acid esters of 5-ene-3 beta-hydroxysteroids, pregnenolone and dehydroisoandrosterone are present in the adrenal. Subsequently, others have shown the existence of these non-polar 5-ene-3 beta-hydroxysteroidal esters in blood, brain and ovaries. Currently, almost every family of steroid hormone is known to occur in esterified form. We have studied the esters of the estrogens and glucocorticoids in some detail, and have found that these two steroidal families are esterified by separate enzymes. In a biosynthetic experiment performed simultaneously with estradiol and corticosterone, we established that the fatty acid composition of the steroidal esters is quite different. The corticoid is composed predominantly of one fatty acid, oleate, while the estradiol esters are extremely heterogeneous. Our studies have demonstrated that the estrogens are extremely long-lived hormones, that they are protected by the fatty acid from metabolism. They are extremely potent estrogens, with prolonged activity. Esterification appears to be the only form of metabolism that does not deactivate the biological effects of estradiol. We have demonstrated the biosynthesis of fatty acid esters of estriol, monoesters at both C-16 alpha and C-17 beta. They too are very potent estrogens. These fatty acid esters of the estrogens are the endogenous analogs of estrogen esters, like benzoate, cypionate, etc., which have been used for decades, pharmacologically because of their prolonged therapeutic potency. We have found that the estradiol esters are located predominantly in hydrophobic tissues, such as fat. Sequestered in these tissues, they are an obvious reservoir of estrogenic reserve, requiring only an esterase for activation. To the contrary the biological activity of the fatty acid esters of the glucocorticoid, corticosterone, is not different from that of its free parent steroid. We have shown that the rapid kinetics of its induction of gluconeogenic responses is caused by its labile C-21 ester which is rapidly hydrolyzed by esterase enzymes. While it appears that the physiological role of the estrogen esters may be related to their long-lived hormonal activity, the role of the other families of steroidal esters is not yet apparent. They, and perhaps the estrogen esters as well, must serve other purposes. Indeed they may serve important biological functions beyond those which we ordinarily associate with steroid hormones.

Estrogenic action of estriol fatty acid esters

Recent studies suggest that, estriol, like estradiol, is biosynthetically esterified with fatty acids. We have synthesized the stearate estriol, at C-16 alpha, C-17 beta and the diester, C-16 alpha,17 beta and tested these D-ring esters for their estrogenic action both in vivo and in vitro, comparing them to estradiol, estriol and estradiol-17-stearate. None of the estriol esters bind to the estrogen receptor. They are only weakly estrogenic in a microtiter plate estrogen bioassay: stimulation of alkaline phosphatase in the Ishikawa endometrial cells. However, both estriol monoesters are extremely potent estrogens when injected subcutaneously (in aqueous alcohol) into ovariectomized mice. Compared to the free steroids, they produced a dramatically increased uterine weight with a greatly prolonged duration of stimulation. The 16 alpha,17 beta-diester also induced a protracted uterotrophic response, but the stimulation of uterine weight was comparatively low. Since the esters of estradiol and estriol do not bind to the estrogen receptor, their estrogenic signal must be generated through the action of esterase enzymes. These naturally occurring esters have the potential of being extremely useful pharmacological agents for long-lived estrogenic stimulation.

Radioisotope assay for glutamine synthetase using thinlayer chromatography

Abstract A simple radiochemical method for the determination of glutamine synthetase activity by thin-layer chromatography is described. The assay involves the separation of glutamine from glutamic acid on anion-exchange resin (Dowex 1(CH 3 COO − ] coated plastic strips. The technique described is fast, reproducible and at least 50 times more sensitive than commonly used colorimetric methods. This method was used to determine the kinetic properties of glutamine synthetase and is applicable with either purified enzymes or crude tissue homogenates. K M values for glutamic acid, ATP and ammonia determined by the present assay were similar to the values obtained by colorimetric methods.

Bovine retinal glutamine synthetase 1. Purification, characterization and immunological properties.

Glutamine synthetase (GS) from bovine retina was purified to apparent homogeneity by ammonium sulfate fractionation followed by Sephacryl S-200, hydroxylapatite, and Sephadex G-150 chromatography. The purified enzyme showed a single band on polyacrylamide gel electrophoresis. Based on the purification data, retinal GS was shown to be approximately 2% of the total soluble retinal protein. By gel filtration, sedimentation velocity centrifugation, and gel electrophoresis, it was shown that the enzyme has a subunit molecular weight of 45 000 daltons and a native molecular weight of 360 000 daltons, which is consistent with an octameric structure. Throughout the various stages of purification, it was found that GS and glutamyl transferase (GT) activities were maintained at a constant ratio. Thus, the GS and GT reactions are catalyzed by the same enzyme. Immunodiffusion of antiretinal GS antibodies gave a single line of precipitation with both crude retinal and brain enzymes as well as purified enzyme preparations. Precipitation lines of retinal and brain enzymes completely fused with each other without any spur formation. The immunochemical titration of brain enzyme activity with antiretinal GS antibodies also revealed an immunological homology between retinal and brain enzymes.

Aromatase and testosterone fatty acid esters: the search for a cryptic biosynthetic pathway to estradiol esters

The estradiol fatty acid esters (lipoidal derivatives, LE2) are extremely potent estrogens that accumulate in fat, including fat of menopausal women. These steroidal esters are protected from metabolism and are converted to the free, biologically active steroid through the action of esterases. Previous studies have shown that biosynthetic pathways in the adrenal gland exist in which steroid fatty acid esters are substrates. This led us to determine whether a cryptic aromatase pathway exists in which testosterone esters could be converted directly into LE2. We tested a representative fatty acid ester, testosterone stearate, both as an inhibitor and as a substrate for the aromatase enzyme from human placental microsomes. This ester had neither activity. In addition, we tested [1 beta-3H]testosterone acetate as a substrate for this enzyme complex, measuring the production of 3H2O as evidence of aromatization. Although the rate of reaction was considerably slower than that of testosterone, 3H2O was produced. However, when [2, 4, 6, 7-3H]testosterone acetate was incubated and the steroidal products isolated, we found that hydrolysis of the substrate had occurred. Both [3H]-labeled testosterone and estradiol were found, and very little if any [3H]estradiol acetate was formed. Thus, we conclude that an aromatase pathway involving testosterone esters does not exist and that the sole source of LE2 is through direct esterification of estradiol.

Bovine retinal glutamine synthetase 2. Regulation and properties on the basis of glutamine synthetase and glutamyl transferase reactions

Glutamine, the end product formed by the glutamine synthetase (GS) reaction, inhibits retinal GS activity in the presence of Mn2+, but not in the presence of Mg2+. In the presence of Mg2+, Mn2+ itself inhibits retinal GS activity. Other compounds which inhibit retinal GS activity significantly are methionine sulfoximine, D-alanine and carbamyl phosphate. Amino acids, such as L-alanine, L-serine and glycine, do not affect the enzyme activity. These amino acids, however, significantly inhibit the enzyme activity when measured on the basis of the glutamyl transferase (GT) reaction. GS isolated from neuronal tissues is regulated differently from that previously reported by others for non-neuronal tissues. The enzyme activity, as measured by GS activity, shows three-fold higher activity with Mg2+ over Mn2+ or Co2+ and on the basis of GT activity, shows about three-fold higher activity with Mn2+ over Mg2+ or Co2+. The optimum pH for the GS reaction lies in the range of 7.2-7.8 and for the GT reaction is 6.4-7.0. Both the GS and GT activities of the enzyme show similar heat stabilities.

Use of reversed-phase high-performance liquid chromatography for simultaneous determination of glutamine synthetase and glutamic acid decarboxylase in crude extracts

Glutamine and gamma-aminobutyric acid (GABA), formed from glutamic acid in crude tissue extracts by glutamine synthetase and glutamic acid decarboxylase respectively, were separated by derivatization with dansyl chloride followed by reversed-phase high-performance liquid chromatography on the Altex Ultrasphere ODS-5 column. The mobile phase was a gradient of 100 mM potassium dihydrogen phosphate (pH 2.1) with 0-40% acetonitrile. The amounts of glutamine and GABA formed from glutamic acid were determined under different reaction conditions.

Use of an Optimum Wavelength to Detect Glutamic Acid and its Metabolites in Human Serum by Reversed-Phase HPLC

Abstract Dansylated glutamic acid, glutamine and γ-amino butyric acid (GABA) show maximum absorption at 221 nm. Using this wavelength, the detection limits for dansylated amino acids studied by reversed-phase HPLC are similar to those reported by fluorescence. This technique was used to look foe the presence of glutamic acid and its metabolites in human serum. Glutamic acid and glutamine were present in significant amounts and their levels were 2.5 and 6.1 nmoles/ml respetively, while GABA was present in trace amounts, less than 0.3 nmoles/ml.